Association of the C-Reactive Protein-Triglyceride-Glucose Index with Stroke-Heart Syndrome and Clinical Prognosis in

Related Experiment Videos

Wenjie Chen1, Xuesong Bai2, Tao Wang2

  • 1Department of Cardiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.

Insights

The C-reactive protein-triglyceride-glucose index (CTI) predicts cardiac injury and poor outcomes in acute ischemic stroke (AIS) patients. This simple index helps identify high-risk individuals for stroke-heart syndrome after AIS.

Area of Science:

  • Cardiology
  • Neurology
  • Biomarkers

Background:

  • Stroke-heart syndrome (SHS), including acute myocardial injury, is a severe complication of acute ischemic stroke (AIS).
  • The C-reactive protein-triglyceride-glucose index (CTI) combines inflammatory and metabolic markers.
  • The predictive value of CTI for cardiac complications post-AIS is unknown.

Purpose of the Study:

  • To investigate if the CTI can predict cardiac injury patterns in AIS patients.
  • To determine if CTI predicts 90-day clinical outcomes, including functional status and mortality, in AIS patients.

Main Methods:

  • A retrospective cohort study of 493 AIS patients undergoing endovascular treatment (EVT) at two centers.
  • Cardiac troponin I (cTnI) trajectories were categorized into no injury, non-dynamic elevation, and dynamic elevation.
  • Primary endpoint: poor functional status (modified Rankin Scale [mRS] 3-6) at 90 days. Secondary endpoint: 90-day all-cause death.

Main Results:

  • Higher baseline CTI correlated with increased likelihood of dynamic troponin elevation (aOR=1.56).
  • Dynamic troponin elevation was linked to significantly worse outcomes compared to no injury.
  • Elevated CTI independently predicted poor 90-day functional outcome (Q4: aOR=3.04) and mortality (Q4: aOR=2.82).

Conclusions:

  • The CTI serves as a predictor of stroke-heart syndrome (SHS) in AIS patients treated with EVT.
  • The CTI is associated with adverse 90-day clinical outcomes.
  • This easily calculated CTI index can aid in identifying AIS patients at higher risk for cardiac complications.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...